Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.
Sato S, Shoji T, Jo A, Otsuka H, Abe M, Tatsuki S, Chiba Y, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T. Sato S, et al. Among authors: kagabu m. Cancers (Basel). 2024 Jul 15;16(14):2545. doi: 10.3390/cancers16142545. Cancers (Basel). 2024. PMID: 39061184 Free PMC article. Review.
High cost of chemotherapy for gynecologic malignancies.
Takahashi N, Seki T, Sasaki K, Machida R, Ishikawa M, Yunokawa M, Matsuoka A, Kagabu M, Yamaguchi S, Hiranuma K, Ohnishi J, Sato T. Takahashi N, et al. Among authors: kagabu m. Jpn J Clin Oncol. 2024 Oct 3;54(10):1078-1083. doi: 10.1093/jjco/hyae089. Jpn J Clin Oncol. 2024. PMID: 39023439
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Chiba Y, Kagabu M, Osakabe M, Ito R, Sato S, Takatori E, Kaido Y, Nagasawa T, Shoji T, Yanagawa N, Baba T. Chiba Y, et al. Among authors: kagabu m. Jpn J Clin Oncol. 2024 Apr 6;54(4):424-433. doi: 10.1093/jjco/hyad192. Jpn J Clin Oncol. 2024. PMID: 38251744
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Maekawa S, Takata R, Sekiguchi K, Kagabu M, Toyoshima M, Tamada S, Takahashi K, Ikarashi D, Matsuura T, Kato R, Kato Y, Kanehira M, Sugimura J, Abe T, Baba T, Obara W. Maekawa S, et al. Among authors: kagabu m. Jpn J Clin Oncol. 2024 Apr 6;54(4):489-497. doi: 10.1093/jjco/hyad185. Jpn J Clin Oncol. 2024. PMID: 38157885
49 results